SUBSCRIBE
SUBSCRIBE
News   Drug Development

GlaxoSmithKline Says 5 Late-Stage Flu Trials Met Goals

October 22, 2012 | 
1 min read
GlaxoSmithKline Plc said results from five late-stage trials of two experimental quadrivalent influenza vaccines (QIV) met the main goal of protecting against mild as well as moderate-severe cases of influenza.
Clinical research Phase 3 Europe
GlaxoSmithKline
MORE ON THIS TOPIC
Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS).
FDA
FDA Reverses Course on Moderna’s mRNA Flu Shot Application, Promising August Decision
February 18, 2026
 · 
3 min read
 · 
Heather McKenzie
Podcast
Modernagate Fallout, Disc’s Rejection, Compass’ Psilocybin Data, CDC’s Lost Leaders
February 18, 2026
 · 
1 min read
 · 
Heather McKenzie
illustration of doubtful man thinks whether to jump to the other side of the mountain, dilemma concept
Rare disease
Disc’s Regulatory Comeback Plan for Rejected Drug Relies on Old FDA Leadership
February 17, 2026
 · 
3 min read
 · 
Annalee Armstrong
Mountain climbing route to peak. Business journey path in progress to peak of success. Climbing road to top. Vector illustration
Psychedelics
Compass’ Psychedelic Shows Durability ‘In Spades’ as Path to FDA Clears
February 17, 2026
 · 
3 min read
 · 
Heather McKenzie